Antibodies are pivotal in immunology, driving advancements in precision medicine with monoclonal antibodies, ADCs, and ...

In patients with Guillain-Barré syndrome, tanruprubart yielded significant improvements in muscle strength, with patients ...

An ancient molecule that existed long before the circulatory system evolved has been found to support cancer immunotherapy.

Scientists have advanced the field of cancer treatment by leveraging the body’s immune system to recognize and target tumors.

First global approval of a once-daily, orally administered, Complement Factor B inhibitorApproval based on robust efficacy and safety data from Haisco's broad completed clinical development program in ...

First global approval of a once-daily, orally administered, Complement Factor B inhibitorApproval based on robust efficacy and safety data from ...

First global approval of a once-daily, orally administered, Complement Factor B inhibitorApproval based on robust efficacy and safety data from ...

Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...

Researchers published findings on June 3, 2026, describing an oral pill that burns fat by targeting skeletal muscle and brown ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

Johnson & Johnson has stopped development of an eye disease gene therapy after reviewing data from one of its key readouts for 2026. Exiting the first quarter, J&J named (PDF) data from the phase 2b ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...